OBJECTIVE: To describe the findings and course of myositis in primary Sjögren's syndrome (SS). METHODS: We studied myositis in SS when clinically indicated. Of 104 patients with SS, we identified 3 cases. In all, the diagnosis was made according to clinical data, biochemical, electromyographic and biopsy criteria. Other autoimmune diseases were excluded. RESULTS: We found a prevalence of 3% of myositis secondary to SS. There were no significant associations between myositis and other clinical or laboratory variables. CONCLUSION: Although rare, myositis must be considered a part of the spectrum of SS. In our experience, treatment with steroids and immunosuppressive drugs was successful.
OBJECTIVE: To describe the findings and course of myositis in primary Sjögren's syndrome (SS). METHODS: We studied myositis in SS when clinically indicated. Of 104 patients with SS, we identified 3 cases. In all, the diagnosis was made according to clinical data, biochemical, electromyographic and biopsy criteria. Other autoimmune diseases were excluded. RESULTS: We found a prevalence of 3% of myositis secondary to SS. There were no significant associations between myositis and other clinical or laboratory variables. CONCLUSION: Although rare, myositis must be considered a part of the spectrum of SS. In our experience, treatment with steroids and immunosuppressive drugs was successful.
Authors: Maria Misterska-Skóra; Agata Sebastian; Piotr Dzięgiel; Maciej Sebastian; Piotr Wiland Journal: Rheumatol Int Date: 2012-12-12 Impact factor: 2.631
Authors: Andrés Hormaza-Jaramillo; Vanessa Bedoya-Joaqui; Germán Puerta-Sarmiento; Mario Bautista; Lady J Rios-Serna; Tatiana Delgado-Mora; Ivana Nieto-Aristizábal; Ingrid Ruiz-Ordoñez Journal: Front Med (Lausanne) Date: 2022-08-15
Authors: Michail P Migkos; Ioannis Sarmas; George A Somarakis; Paraskevi V Voulgari; Konstantinos I Tsamis; Alexandros A Drosos Journal: Mediterr J Rheumatol Date: 2018-06-29